AAAAAA

   
Results: 1-5 |
Results: 5

Authors: Giannini, S Cresci, B Pala, L Ciucci, A Franchini, A Manuelli, C Fujita-Yamaguchi, Y Cappugi, P Zonefrati, R Rotella, CM
Citation: S. Giannini et al., IGFBPs modulate IGF-I- and high glucose-controlled growth of human retinalendothelial cells, J ENDOCR, 171(2), 2001, pp. 273-284

Authors: Giannini, S Cresci, B Pala, L Ciucci, A Manuelli, C Fujita-Yamaguchi, Y Cappugi, P Rotella, CM
Citation: S. Giannini et al., Human glomerular endothelial cells IGFBPs are regulated by IGF-I and TGF-beta(1), MOL C ENDOC, 154(1-2), 1999, pp. 123-136

Authors: Parronchi, P Brugnolo, F Annunziato, F Manuelli, C Sampognaro, S Mavilia, C Romagnani, S Maggi, E
Citation: P. Parronchi et al., Phosphorothioate oligodeoxynucleotides promote the in vitro development ofhuman allergen-specific CD4(+) T cells into Th1 effectors, J IMMUNOL, 163(11), 1999, pp. 5946-5953

Authors: Piccinni, MP Bani, D Beloni, L Manuelli, C Mavilia, C Vocioni, F Bigazzi, M Sacchi, TB Romagnani, S Maggi, E
Citation: Mp. Piccinni et al., Relaxin favors the development of activated human T cells into Th1-like effectors, EUR J IMMUN, 29(7), 1999, pp. 2241-2247

Authors: Mori, M Manuelli, C Pimpinelli, N Mavilia, C Maggi, E Santucci, M Bianchi, B Cappugi, P Giannotti, B Kadin, ME
Citation: M. Mori et al., CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression, BLOOD, 94(9), 1999, pp. 3077-3083
Risultati: 1-5 |